|
Maximum severity of adverse events in each 6 patients. |
|||||||
| NCI-CTC grade |
|||||||
|
|
|||||||
| Case# |
|||||||
|
|
|||||||
| #1 |
#2 |
#3 |
#4 |
#5 |
#6 |
||
|
|
|||||||
| Hematological |
|||||||
| Leukopenia |
0 |
0 |
0 |
3 |
0 |
2 |
|
| Neutropenia |
0 |
0 |
1 |
2 |
0 |
2 |
|
| Anemia |
1 |
1 |
1 |
2 |
1 |
0 |
|
| Thrombocytopenia |
0 |
0 |
0 |
0 |
0 |
0 |
|
| Gastrointestinal |
|||||||
| Appetite loss |
1 |
1 |
1 |
2 |
1 |
0 |
|
| Diarrhea |
0 |
1 |
3 |
3 |
3 |
3 |
|
| Nausea/vomiting |
1 |
1 |
0 |
2 |
1 |
0 |
|
| Abdominal pain |
1 |
1 |
1 |
3 |
1 |
2 |
|
|
Grade 3 diarrhea occurred at day 18 (#3), 25 (#4), 21 (#5), and 19 (#6) Case #4 had bowel fistula which required surgical intervention. | |||||||
Yasui et al. World Journal of Surgical Oncology 2006 4:83 doi:10.1186/1477-7819-4-83 |
|||||||